Brantley R Herrin

Title: Brantley R Herrin: Innovator in Biomedical Research

Introduction

Brantley R Herrin is a notable inventor based in Decatur, GA, with a significant contribution to the field of biomedical research. He holds a total of 9 patents, showcasing his innovative approach to addressing complex medical challenges. His work primarily focuses on the development of variable lymphocyte receptors that have the potential to revolutionize treatments for various diseases.

Latest Patents

Herrin's latest patents include groundbreaking discoveries such as variable lymphocyte receptors that target the blood-brain barrier and methods of use. This patent provides isolated polypeptides that specifically bind to the blood-brain barrier, along with compositions and methods for their application. Another significant patent involves variable lymphocyte receptors that target the brain extracellular matrix, offering isolated polypeptides that bind to this matrix, along with their respective compositions and methods. Additionally, he has developed methods for using these variable lymphocyte receptors in the detection and treatment of diseases, particularly cancers like glioblastoma.

Career Highlights

Throughout his career, Brantley R Herrin has worked with esteemed institutions such as Emory University and the UAB Research Foundation. His research has contributed to advancements in understanding and treating complex medical conditions, particularly in the realm of cancer therapy.

Collaborations

Some of Herrin's notable collaborators include Max Dale Cooper and Matthew N Alder. Their combined expertise has further enhanced the impact of Herrin's research and innovations in the biomedical field.

Conclusion

Brantley R Herrin's contributions to biomedical research through his patents and collaborations highlight his role as a leading innovator in the field. His work continues to pave the way for new therapeutic approaches to challenging medical conditions.